Portfolio Company · Operating Co.
SERI (Singapore Eye Research Institute) Spin-off? (Various healthcare assets)
Healthcare
SERI (Singapore Eye Research Institute) Spin-off? (Various healthcare assets)backed byAffinity Equity Partners
CurrentHealthcare
Company Snapshot
SERI (Singapore Eye Research Institute) Spin-off? (Various healthcare assets) is a healthcare portfolio company held by Affinity Equity Partners, with parent firm headquartered in Singapore, Singapore. Profile compiled from public sources; submit updates to extend the public record.
Ownership Context
SERI (Singapore Eye Research Institute) Spin-off? (Various healthcare assets) is a current portfolio company of Affinity Equity Partners, headquartered in Singapore, Singapore. Public coverage of this company is grouped under its parent firm's profile.
Sources
www.affinityequity.com/portfolio-companiesThis profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with SERI (Singapore Eye Research Institute) Spin-off? (Various healthcare assets) and does not provide investment advice.
Other portfolio companies of Affinity Equity Partners
Affinity Equity Partners
Burger King (Korea & Japan)
Consumer & Retail
Burger King Japan
Consumer/Retail
Burger King Japan / Korea
Consumer/Retail
Burger King Korea
Consumer/Retail
CJ CGV
Consumer & Retail
Fairchild Semiconductor
TMT
Galderma
Healthcare
See the full Affinity Equity Partners portfolio.
Other Healthcare portfolio companies
123Dentist
via kkr
A Place for Mom
via warburg pincus
A-S Medication Solutions (ASMS)
via warburg pincus
AA Medical Health
via warburg pincus
Abacus Pharmaceuticals
via the carlyle group
Abacus Pharmaceuticals
via carlyle group
Abbisko
via the carlyle group
Abbisko
via carlyle group
Browse all PE-backed companies.